The Trump administration hopes to issue a rule by the end of this year empowering regulators to “very forcefully” go after companies that don’t share information on drug costs, the CMS administrator said Tuesday.
The Trump administration hopes to issue a rule by the end of this year empowering regulators to “very forcefully” go after companies that don’t share information on drug costs, the CMS administrator said Tuesday.